Healthcare
Obesity medication coverage restricts access and excludes primary care
Starting from February 2027, the state will provide a 15% subsidy for obesity medication. This subsidy is only applicable if the medication is prescribed by endocrinologists, internal medicine doctors, or pediatricians, effectively excluding prescriptions from primary care physicians (family doctors).
Why it matters
If you are seeking treatment for obesity, you will only be eligible for the 15% state subsidy if your prescription is issued by a specialist, meaning you cannot receive this coverage through your regular family doctor in the SNS primary care system.Correio da ManhãRead original ↗
